Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. This all creates numerous challenges for the market. Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

Gene Therapy 59

Gene Therapy Gene Bioinformatics Life Science 59

Drug Discovery World

MARCH 29, 2023

Julian Collins, Jana Windt and Michiel Stork, ProBioGen Julian Collins has been appointed as Senior Vice President, Head of People & Organizational Development (P&OD) and a member of the Executive Team. In 2022, he was awarded a Commander of the Order of the British Empire (CBE) for services to UK Life Science.

Life Science 52

Life Science DNA Business Development Drugs 52

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. This all creates numerous challenges for the market. Dr O’Hara also provided an AAV plasmid preparation case study. Why are those important?

Gene Therapy 52

Gene Therapy Gene Life Science Bioinformatics 52

Drug Discovery World

MAY 25, 2023

Several new products for the life sciences sector have been launched over the last month, from miniature semiconductor chip (MSC) technology to a new inhalation testing service. It is accessible, boosts developer productivity and aims to save up to 80% of the time and cost associated with traditional API management strategies.

Production 52

Production Reagent DNA Drugs 52

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Drug Discovery World

FEBRUARY 6, 2024

From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows, digital technologies are having a significant impact on drug discovery and development. The company’s platform evaluated more than 11.4

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

JUNE 10, 2024

A new facility has opened in Cardiff, UK designed to manufacture patient-derived organoids (PDOs) at scale for use in drug discovery and development. Evans was awarded the 2007 Nobel Prize for Medicine for ground-breaking discoveries concerning the discovery of mammalian embryonic stem cells and DNA recombination.

Manufacturing 59

Manufacturing Drugs Life Science Medicine 59

XTalks

NOVEMBER 28, 2023

Kesin Pharma is headquartered in New York and focuses on the development, manufacturing and commercialization of generic and innovative products in liquid and semi-solid dosage forms. Alternative Products in the Market In addition to the oral suspension Likmez, there are alternative FDA-approved treatments for similar indications.

FDA Approval 103

FDA Approval Bacteria DNA Drugs 103

XTalks

MARCH 13, 2024

Related: Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments — Featuring Pierre Simon, VP Marketing, Sight Sciences – Xtalks Life Science Podcast Ep. As this technology continues to evolve, it is expected to help identify glaucoma in its nascent stages of development.

Gene Therapy 111

Gene Therapy Gene Life Science DNA 111

Drug Discovery World

JANUARY 30, 2023

DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. Despite consisting of largely small enterprises, Lithuania is still home to some large players in the life sciences sector including Thermo Fisher Scientific, Teva and Northway Biotech.

Life Science 98

Life Science Genome Genomics Development 98

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” About INOVIO’s DNA Medicines Platform. mg and 2.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

XTalks

JUNE 16, 2023

XTALKS WEBINAR: Point-of-Care Diagnostics: Best Practices for Bringing Novel Solutions to Market Live and On-Demand: Thursday, July 13, 2023, at 1pm EDT (10am PDT) Register for this free webinar to gain insights from industry leaders on best practices for commercializing point-of-care diagnostic innovations. billion in 2022 to $15.91

FDA Approval 97

FDA Approval Genome Genomics DNA 97

Drug Discovery World

OCTOBER 16, 2023

Cambridge boasts the world-renowned university alongside a biotech and pharma cluster situated throughout the city and its surrounding science parks, all of which helps attract top scientific talent.” The university aims to identify treatments for life-threatening anti-microbial diseases and metabolic disorders. billion in funding.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

Drug Discovery World

JULY 22, 2022

To date, the centre has helped 27 companies achieve a combined market capitalisation of £790 million. . Synthetic biology is an emerging field of science that combines methodologies from engineering and biology to design or re-design biological systems to produce useful and sustainable new products. SynbiCITE .

DNA 52

DNA Life Science Engineer Development 52

The Pharma Data

OCTOBER 19, 2020

20, 2020 /PRNewswire/ — Caris Life Sciences® , a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Winship Cancer Institute of Emory University (Winship) has joined Caris’ Precision Oncology Alliance (The Alliance/POA). . Ramalingam , M.D.,

Life Science 52

Life Science Clinical Trials Clinical Trials RNA 52

The Pharma Data

JANUARY 5, 2021

Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Genome 52

Genome Genomics Life Science Development 52

XTalks

SEPTEMBER 28, 2020

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The test was developed by Resolution Bioscience and the company will run test analyses in its labs. In the US, Medicare covers the test.

Gene 105

Gene DNA Life Science Genotype 105

The Pharma Data

JANUARY 31, 2021

NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. 1, 2021 00:00 UTC.

Genome 52

Genome Genomics Life Science DNA 52

pharmaphorum

AUGUST 27, 2020

The Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), works with universities, research organisations, businesses, charities, and government to develop a supportive ecosystem. The first is that the development of vaccines is utilising cutting edge technologies.

Vaccination 123

Vaccination Vaccine Life Science Clinical Trials 123

Drug Discovery World

FEBRUARY 13, 2023

What is important is how we use it, and SLAS2023 is taking the necessary next steps through a diverse range of talks and presentations, which ask: How has life sciences technology pushed innovation to boost the drug discovery process? How can technology help drug discovery research get to market faster and at optimum efficiency?

Genome 52

Genome Genomics Life Science Drugs 52

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. The development and widespread adoption of new technologies is key to revolutionizing the way we diagnose, prevent, treat and manage disease. They can be developed and adapted quickly.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Drug Discovery World

APRIL 25, 2024

Reece Armstrong offers an overview of cell line development and outlines the benefits the technology is bringing to biopharmaceutical developers. Cell line development is an essential underpinning of the drug development process, enabling teams to test, optimise and manufacture therapeutics at a commercial scale.

Development 59

Development Protein In-Vivo Life Science 59

XTalks

MARCH 16, 2022

She explained that she “wanted to prevent other families from experiencing this kind of tragedy and decided to dedicate [herself] to educating people about the life-changing power of screening.”. It detects altered DNA and/or blood in stool and finds 92 percent of colon cancers.

DNA 98

DNA FDA Approval Doctors Doctor 98

Drug Discovery World

JULY 31, 2023

Matt Hill , Founder and CEO of Elegen writes about the importance of innovation in DNA synthesis to address critical bottlenecks in biotherapy development. With advanced technology and a growing understanding of the underlying biology, biotherapy development has evolved.

DNA 52

DNA Medicine Manufacturing Production 52

Drug Discovery World

JUNE 5, 2023

New approaches to partnering In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed John McDonald, Corporate Vice President, Global R&D Business Development, Novo Nordisk. The panel was moderated by Alexander Nuyken, Head Life Sciences Markets Europe, Middle East & Africa, JLL.

Genome 52

Genome Genomics Life Science Genetics 52

Pharma Marketing Network

SEPTEMBER 15, 2021

for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries. ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. Fairfield, N.J. (15 and Otsuka America Pharmaceutical, Inc.

Life Science 52

Life Science DNA Branding Development 52

XTalks

DECEMBER 13, 2023

The landmark approvals were awarded to bluebird bio’s Lyfgenia (lovo-cel) and Vertex Pharmaceuticals and CRISPR Therapeutics’ jointly developed Casgevy (exa-cel). The CRISPR system is dubbed to be molecular “scissors” that can cut out parts of genes that are abnormal, deactivating or replacing them with new strands of normal DNA.

Gene Therapy 98

Gene Therapy FDA Approval Gene In-Vivo 98

Pharma Marketing Network

OCTOBER 7, 2022

for game-changing initiatives working to close the gender gap in the healthcare and life science industries. ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. Fairfield, N.J. (20 HBA’s Advancement. Commitment. Engagement.

Life Science 52

Life Science DNA Development Marketing 52

Roots Analysis

JANUARY 28, 2024

By analyzing this data, healthcare organizations can identify patterns and trends, predict patient outcomes, and develop personalized treatment plans. Conclusion Owing to the increasing popularity of big data in healthcare domain, there is a huge impact of big data in healthcare market size.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

Pharma Marketing Network

NOVEMBER 23, 2021

ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA.”. In areas that have been historically underrepresented, Merck is outpacing market availability by creating a workplace where woman can accelerate and reach their full potentials.

Life Science 52

Life Science DNA Branding Marketing 52

XTalks

DECEMBER 4, 2023

The FDA said it is investigating the identified risk of developing the T-cell malignancies as secondary cancers with serious outcomes, including hospitalization and death, and also looking at the need for regulatory action. Novartis and BMS echoed similar sentiments regarding their respective therapies.

Gene Therapy 69

Gene Therapy Gene Clinical Trials Clinical Trials 69

XTalks

NOVEMBER 7, 2022

Liquid biopsy tests in oncology involve isolating entities such as circulating tumor cells (CTC), circulating tumor DNA (ctDNA) and tumor-derived exosomes. In addition, Dr. Bahassi stressed that the simple enumeration of CTCs will not contribute significantly to the development of improved or more personalized cancer treatments.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Drug Discovery World

AUGUST 3, 2023

For example, the FDA has not approved a marketing application for cannabis for the treatment of any disease or condition to date 1. With these exceptions, no other cannabis, cannabis-derived, or cannabidiol (CBD) products are FDA-approved and therefore on the market 1. This was the largest ever independent study into cannabis use 10.

Medicine 52

Medicine Scientist Production Regulation 52

Delveinsight

JANUARY 14, 2021

Gilead Sciences, Inc. announced that the companies have entered into a clinical collaboration to assess novel therapeutic combination strategies to develop a functional remedy for chronic hepatitis B virus (HBV). The treatment, VERVE-101, is a base editor; that is, it does not cut DNA as CRISPR gene editing systems do.

Gene Editing 40

Gene Editing Gene Genetics DNA 40

Delveinsight

SEPTEMBER 2, 2021

This designation was based on positive clinical data from the first 21 Impella ECP patients treated as part of an FDA-regulated early feasibility study and will give priority during the Impella ECP’s regulatory review processes comprising of design iterations, clinical study protocols, and pre-market approval (PMA) application.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72